Literature DB >> 7049248

Inactivation of human plasma alpha 1-proteinase inhibitor by a metalloproteinase from Serratia marcescens.

G D Virca, D Lyerly, A Kreger, J Travis.   

Abstract

The interaction of a Serratia marcescens metalloproteinase with human plasma alpha 1-proteinase inhibitor has been investigated. The enzyme was not inactivated by this inhibitor but, instead, converted the native plasma protein into an inactive form of decreased molecular weight. Amino terminal sequence analysis indicated that the interaction of the inhibitor and enzyme was at the reactive site of the inhibitor, with peptide-bond cleavage resulting in the inactivation. This process may be important in necrotic processes occurring during bacterial infiltration of host tissues.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049248     DOI: 10.1016/0167-4838(82)90155-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens.

Authors:  A Molla; T Akaike; H Maeda
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils.

Authors:  M C Vissers; P M George; I C Bathurst; S O Brennan; C C Winterbourn
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture.

Authors:  A Molla; K Matsumoto; I Oyamada; T Katsuki; H Maeda
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens.

Authors:  A Molla; T Kagimoto; H Maeda
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

5.  Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulin.

Authors:  A Molla; Y Matsumura; T Yamamoto; R Okamura; H Maeda
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

6.  The structural basis for neutrophil inactivation of C1 inhibitor.

Authors:  P A Pemberton; R A Harrison; P J Lachmann; R W Carrell
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

7.  Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.

Authors:  André Weiss; Hanna Joerss; Jens Brockmeyer
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

8.  Multiplex quantification of C-terminal alpha-1-antitrypsin peptides provides a novel approach for characterizing systemic inflammation.

Authors:  Arite Bigalke; Christoph Sponholz; Claudia Schnabel; Michael Bauer; Michael Kiehntopf
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.